GLP-1 Market
LLY $1138.28 ▲ +2.0% NVO $43.45 ▲ +0.9% PFE $27.72 • 0.0% VKTX $31.53 ▼ -1.4% KLRA $13.75 ▼ -1.4% GPCR $38.44 ▼ -0.6% RHHBY $54.80 ▲ +3.9%
Market data delayed up to 20 min · Source: Twelve Data

Empowering you to have better conversations with your doctor.

Subscribe
About this data Sourced primarily from ClinicalTrials.gov — a listing isn't proof of safety or FDA approval.

Pipeline and clinical trial information here comes primarily from ClinicalTrials.gov. A listing on ClinicalTrials.gov means a study has been registered — not that a treatment is proven safe, effective, or FDA-approved. Investigational treatments may never be approved. Who can join a trial is decided only by that trial's own study team.

Not yet reported

Rabeprazole Sodium

Company
Nantes University Hospital
Mechanism
Mechanism not yet reported
Route
Route not yet reported
Recruiting trials
11 recruiting

Efficacy results: Not yet reported

Find a Clinical Trial Near Me

11 recruiting studies currently listed on ClinicalTrials.gov.

Data source: ClinicalTrials.gov · trial data as of Sep 15, 2026

Find a Clinical Trial Near Me

See recruiting studies for Rabeprazole Sodium and check eligibility with the study team.

Select conditions
Match
Treatment type

"Added to GLP-1" means the investigational treatment is being studied on top of an existing GLP-1-based therapy.

Your ZIP code is only used to calculate distance to trial sites — it isn't stored.

Trial details
  • Recruiting NCT NCT04416581

    Potassium-Competitive Acid Blocker Versus pROton-Pump Inhibitor for GastroproTECTion Strategies In Patients at High Gastro-Intestinal Bleeding Risk Receiving Antithrombotic Therapy

    Not yet reported Duk-Woo Park, MD 3320 participants Est. completion 2028-02-28 45 sites Stand-alone
    Cardiovascular disease Other conditions: Percutaneous Coronary Intervention, Acute Coronary Syndrome
    View official trial listing →
  • Recruiting NCT NCT04448028

    Stop of Proton-pump Inhibitor Treatment in Patients With Liver Cirrhosis - a Double-blind, Placebo-controlled Trial

    Not yet reported Universitätsklinikum Hamburg-Eppendorf 476 participants Est. completion 2028-02 1 site
    Other conditions: Liver Cirrhosis
    View official trial listing →
  • Recruiting NCT NCT05332444

    Efficacies of Susceptibility-guided vs Empiric Therapy for Rescue Treatment of Helicobacter Pylori Infection

    Not yet reported National Taiwan University Hospital 450 participants Est. completion 2026-12 1 site Stand-alone
    Other conditions: Helicobacter Pylori Infection
    View official trial listing →
  • Recruiting NCT NCT06349486

    Efficacies of Bismuth-amoxicillin-vonoprazan Triple Therapy, Vonoprazan-amoxicillin Dual Therapy and Proton Pump Inhibitor-based Standard Triple Therapy for Hp Eradication

    Not yet reported Kaohsiung Medical University 390 participants Est. completion 2026-12-31 1 site
    Other conditions: Helicobacter Pylori Eradication
    View official trial listing →
  • Recruiting NCT NCT07010107

    A Clinical Trial of Anaprazole for Treating Reflux Esophagitis.

    Not yet reported Xuanzhu Biopharmaceutical Co., Ltd. 500 participants Est. completion 2026-08 1 site Stand-alone
    Other conditions: Reflux Esophagitis (RE)
    View official trial listing →
  • Recruiting NCT NCT07122024

    Efficacy and Safety of Keverprazan-amoxicillin Dual Therapy for Helicobacter Pylori First-line Treatment

    Not yet reported Second Affiliated Hospital, Zhejiang University, School of Medicine 414 participants Est. completion 2025-12-30 1 site
    Other conditions: Helicobacter Pylori
    View official trial listing →
  • Recruiting NCT NCT07165444

    Potassium-Competitive Acid Blocker Versus Proton Pump Inhibitor as A Part of Bismuth Based Quadruple Therapy for Treatment of Helicobacter Pylori Infection

    Not yet reported Tanta University 320 participants Est. completion 2026-02-01 1 site
    Other conditions: Potassium-Competitive Acid Blocker, Proton Pump Inhibitor, Bismuth Based Quadruple Therapy, Treatment, Helicobacter Pylori Infection
    View official trial listing →
  • Recruiting NCT NCT07358130

    Efficacies of Bismuth-amoxicillin-vonoprazan Triple Therapy and Bismuth Quadruple Therapy

    Not yet reported Kaohsiung Medical University 552 participants Est. completion 2027-12-31 1 site
    Other conditions: Helicobacter Pylori Infection
    View official trial listing →
  • Recruiting NCT NCT07471867

    Effect of ZaStaprazan on Platelet Reactivity of Clopidogrel After PercuTaneous CoronAry InteRvention

    Not yet reported Yonsei University 100 participants Est. completion 2028-07-12 1 site Stand-alone
    Other conditions: Chronic Coronary Syndrome
    View official trial listing →
  • Recruiting NCT NCT07597928

    A Study to Learn How Different Forms of the Study Medicine Called PF-08049820 Are Absorbed and Eliminated in Healthy Adults

    Not yet reported Pfizer 24 participants Est. completion 2026-09-25 1 site Stand-alone
    Other conditions: Healthy Adults, Healthy
    View official trial listing →
  • Recruiting NCT NCT07797478

    A Study of RO7890597 in Healthy Adult Volunteers

    Not yet reported Genentech, Inc. 139 participants Est. completion 2027-06-08 1 site Stand-alone
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT00125736

    A Double-blind, Comparative Study in Patients With Gastric Ulcer to Evaluate the Efficacy of Combination Use of E0671 and Rabeprazole Sodium

    Not yet reported Eisai Co., Ltd. 520 participants Est. completion 2007-04-19 43 sites Stand-alone
    Other conditions: Stomach Ulcer
    View official trial listing →
  • Completed NCT NCT00132496

    Treatment of Gastroesophageal Reflux Disease in 12-16 Year Old Patients With Rabeprazole

    Not yet reported Eisai Inc. 111 participants Est. completion 2006-07 25 sites
    Other conditions: Gastroesophageal Reflux Disease
    View official trial listing →
  • Status unknown NCT NCT00162877

    The Role of CYP2C19 on the Eradication of H. Pylori Infection:Implication of PK/PD Relationships

    Not yet reported National Taiwan University Hospital 80 participants Est. completion 2005-04 1 site
    Other conditions: Peptic Ulcer With H. Pylori Infection, Gastritis With H. Pylori Infection
    View official trial listing →
  • Completed NCT NCT00165646

    A Comparative Study on the Efficacy and Safety of E3810 in Patients With Non-erosive Gastroesophageal Reflux Disease

    Not yet reported Eisai Co., Ltd. 288 participants Est. completion 2005-10 35 sites
    Other conditions: Non-erosive Gastroesophageal Reflux Disease
    View official trial listing →
  • Completed NCT NCT00165672

    A Study of E3810 With Pre- and Post-Treatment pH Monitoring in Patients With Non-Erosive Gastroesophageal Reflux Disease

    Not yet reported Eisai Inc. 26 participants Est. completion 2005-10 13 sites Stand-alone
    Other conditions: Non-erosive Gastroesophageal Reflux Disease
    View official trial listing →
  • Completed NCT NCT00165841

    Maintenance Intermittent Therapy for Symptomatic GERD Patients

    Not yet reported Eisai Inc. 200 participants Est. completion 2008-06 1 site Stand-alone
    Other conditions: Gastroesophageal Reflux Disease
    View official trial listing →
  • Status unknown NCT NCT00197418

    Second Line Therapy for the Cure of Helicobacter Pylori (H. Pylori) Infection

    Not yet reported, Not yet reported Hamamatsu University 1 site
    Other conditions: Helicobacter Infections, Gastritis, Gastric Ulcer, Duodenal Ulcer
    View official trial listing →
  • Completed NCT NCT00199953

    Post-nasal Drainage as an Extraesophageal Manifestation of Reflux

    Not yet reported Medical College of Wisconsin 50 participants Est. completion 2007-12 1 site
    Other conditions: Postnasal Drainage
    View official trial listing →
  • Completed NCT NCT00204698

    Laryngopharyngeal Reflux and Proton Pump Inhibitor (PPI) Treatment

    Not yet reported, Not yet reported University of Utah 24 participants Est. completion 2006-05 1 site
    Other conditions: Laryngopharyngeal Reflux
    View official trial listing →
  • Completed NCT NCT00204750

    Trial of Electrosurgical Incision Versus Bougie Dilation of Symptomatic Lower Esophageal (Schatzki's) Rings

    Not yet reported, Not yet reported University of Utah 50 participants Est. completion 2006-12 1 site
    Other conditions: Lower Esophageal Ring, Dysphagia
    View official trial listing →
  • Completed NCT NCT00214552

    Evaluate the Effects on Asthma Control of Rabeprazole Given Twice Daily in Subjects With Asthma.

    Not yet reported Associated Scientists to Help Minimize Allergies 80 participants Est. completion 2005-03 2 sites
    Other conditions: Asthma, Gastroesophageal Reflux Disease
    View official trial listing →
  • Completed NCT NCT00216450

    Study of the Safety and Effectiveness of Rabeprazole in Treatment of Helicobacter Pylori Infection in Adults.

    Not yet reported Janssen Cilag Pharmaceutica S.A.C.I., Greece 80 participants Est. completion 2006-02
    Other conditions: Helicobacter Infections, Bacterial Infections
    View official trial listing →
  • Completed NCT NCT00216489

    A Study of the Safety of Rabeprazole Administered to Adults With Gastroesophageal Reflux Disease (GERD)

    Not yet reported Janssen Cilag Pharmaceutica S.A.C.I., Greece 191 participants Est. completion 2005-11
    Other conditions: Gastroesophageal Reflux, Heartburn
    View official trial listing →
  • Completed NCT NCT00220857

    Rabeprazole Protection of Aspirin Induced Gastric Damage.

    Not yet reported Temple University 30 participants Est. completion 2007-09 1 site
    Other conditions: Normal Subjects
    View official trial listing →
  • Completed NCT NCT00222170

    Rabeprazole in Subjects With Gastroesophageal Reflux Disease (GERD)

    Not yet reported University of Kansas 24 participants Est. completion 2007-05 1 site
    Other conditions: Esophageal Reflux
    View official trial listing →
  • Completed NCT NCT00234117

    Improvement in Bronchial Asthma in Patients With Extraesophageal Reflux After Acid Suppression

    Not yet reported Ponce Gastroenterology Research 40 participants 1 site
    Other conditions: Bronchial Asthma, Gastroesophageal Reflux
    View official trial listing →
  • Completed NCT NCT00236184

    E3810-A001-313: Efficacy and Safety of 10 mg Rabeprazole for Treating Heartburn in Frequent Sufferers

    Not yet reported Eisai Inc. 629 participants Est. completion 2008-06 1 site Stand-alone
    Other conditions: Heartburn
    View official trial listing →
  • Completed NCT NCT00236197

    E3810-A001-312: Efficacy and Safety of 10 mg Rabeprazole for Treating Heartburn in Frequent Sufferers

    Not yet reported Eisai Inc. 619 participants Est. completion 2008-06 1 site Stand-alone
    Other conditions: Heartburn
    View official trial listing →
  • Completed NCT NCT00236392

    A Study of Efficacy and Safety of "On-demand" Maintenance Therapy With Rabeprazole in Patients With Non-erosive Reflux Disease (NERD)

    Not yet reported Janssen Pharmaceutica N.V., Belgium 422 participants Est. completion 2002-10
    Other conditions: Gastroesophageal Reflux, Heartburn
    View official trial listing →
  • Completed NCT NCT00237367

    A Study of Rabeprazole and Pantoprazole on Stomach Acid and Esophageal Acid Exposure in Patients With Gastroesophageal Reflux Disease (GERD) and a History of Nighttime Heartburn

    Not yet reported PriCara, Unit of Ortho-McNeil, Inc. 52 participants Est. completion 2005-04
    Other conditions: Gastroesophageal Reflux
    View official trial listing →
  • Completed NCT NCT00251732

    Role of Pain Modulation in GERD Patients Who Failed Standard Dose Proton Pump Inhibitors (PPI)

    Not yet reported University of Arizona 150 participants Est. completion 2010-05 1 site
    Other conditions: Gastroesophageal Reflux Disease
    View official trial listing →
  • Completed NCT NCT00287391

    Sleep Disorders and Gastroesophageal Reflux Disease (GERD)

    Not yet reported University of North Carolina 20 participants Est. completion 2006-12 1 site
    Other conditions: Insomnia, GERD
    View official trial listing →
  • Completed NCT NCT00304421

    Comparison of the Nighttime Effects of Two Different Drugs on Subjects With GERD

    Not yet reported VA Greater Los Angeles Healthcare System 23 participants Est. completion 2007-09 1 site
    Other conditions: Gastroesophageal Reflux Disease
    View official trial listing →
  • Completed NCT NCT00354757

    CYP2C19 Genetic Polymorphism on the Accuracy of Proton-Pump Inhibitor Testing

    Not yet reported National Taiwan University Hospital 200 participants Est. completion 2008-12 1 site
    Other conditions: GERD
    View official trial listing →
  • Completed NCT NCT00378287

    A Study to Monitor Intragastric pH in Patients Taking Rabeprazole vs. Patients Taking Pantoprazole

    Not yet reported Janssen-Ortho Inc., Canada 37 participants Est. completion 2005-12
    Other conditions: GERD
    View official trial listing →
  • Completed NCT NCT00464308

    A Study to Compare the Number of Patients With Gastro-Oesophageal Reflux Disease (GORD) Achieving Heartburn and Regurgitation Symptom Resolution After Treatment With Either Rabeprazole Sodium 20mg, Esomeprazole 20mg or Esomeprazole 40mg

    Not yet reported Janssen-Cilag Pty Ltd 1392 participants Est. completion 2008-05 25 sites
    Other conditions: Gastro-oesophageal Reflux
    View official trial listing →
  • Terminated NCT NCT00511745

    Safety of Rabeprazole in Patients Under Multiple Treatments

    Janssen-Cilag, S.A. 2157 participants Est. completion 2002-11
    Other conditions: Gastroesophageal Reflux, Gastric Ulcer
    View official trial listing →
  • Terminated NCT NCT00511966

    Influence of Hygiene-dietetic Habits and Treatment Adherence on the Effectiveness of the Gastroesophageal Reflux Illness Treatment With Rabeprazol

    Janssen-Cilag, S.A. 1049 participants Est. completion 2002-11
    Other conditions: Gastroesophageal Reflux
    View official trial listing →
  • Completed NCT NCT00517114

    Prospective Double-blinded Randomized Controlled Trial of 12-weeks High Dose Rabeprazole (Pariet) in the Treatment of Reflux Laryngitis in Chinese Patients

    Not yet reported Hospital Authority, Hong Kong 200 participants Est. completion 2008-12 1 site
    Other conditions: Gastroesophageal Reflux, Laryngitis
    View official trial listing →
  • Status unknown NCT NCT00517270

    A Study of the Use of High-dose Proton Pump Inhibitor for the Treatment of Gastro-oesophageal Reflux Related Non-cardiac Chest Pain - a Randomized Double-blind Placebo-controlled Study

    Not yet reported Hospital Authority, Hong Kong 200 participants Est. completion 2008-04 1 site
    Other conditions: Chest Pain
    View official trial listing →
  • Completed NCT NCT00534443

    Importance of Cytokines in Peptic Ulcer Disease: Implications for Treatment

    Not yet reported University of Athens 150 participants Est. completion 2009-09 1 site Stand-alone
    Other conditions: Peptic Ulcer
    View official trial listing →
  • Completed NCT NCT00539240

    Role of Pain Modulation in GERD Patients Who Failed Standard Dose PPI

    Not yet reported, Not yet reported US Department of Veterans Affairs 236 participants Est. completion 2011-11 1 site
    Other conditions: Gastroesophageal Reflux Disease
    View official trial listing →
  • Status unknown NCT NCT00539786

    The Proton Pump Inhibitor (PPI) Test for the Extraesophageal Manifestation of GERD

    Not yet reported Samsung Medical Center 100 participants 1 site
    Other conditions: Gastroesophageal Reflux Disease
    View official trial listing →
  • Completed NCT NCT00553449

    Open Label Study Evaluating Different Dosing Regimens of Rabeprazole in Gastro-esophageal Reflux Disease (GERD) Patients With Night-time Heartburn Symptoms.

    Not yet reported Janssen-Ortho Inc., Canada 48 participants Est. completion 2005-09
    Other conditions: Gastroesophageal Reflux, Heartburn
    View official trial listing →
  • Completed NCT NCT00614536

    Study of Changes in Reflux Symptoms and Reflux Finding Score According to Rabeprazole Treatment Period

    Janssen Korea, Ltd., Korea 1142 participants Est. completion 2008-04
    Other conditions: Gastroesophageal Reflux, Pharyngeal Diseases
    View official trial listing →
  • Completed NCT NCT00648349

    Fasting Study of Rabeprazole Sodium Delayed-Release Tablets 20 mg to Aciphex® Delayed-Release Tablets 20 mg

    Not yet reported Mylan Pharmaceuticals Inc 72 participants Est. completion 2003-06 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT00649194

    Food Study of Rabeprazole Sodium Delayed-Release Tablets 20 mg to Aciphex® Tablets 20 mg

    Not yet reported Mylan Pharmaceuticals Inc 72 participants Est. completion 2003-08 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT00649493

    Fed Study of Rabeprazole Sodium Tablets 20 mg and Aciphex® Tablets 20 mg

    Not yet reported Mylan Pharmaceuticals Inc 72 participants Est. completion 2003-06 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT00658528

    Rabeprazole Extended-Release 50 mg Versus Esomeprazole 40 mg for Healing and Symptomatic Relief of Moderate to Severe Erosive Gastroesophageal Reflux Disease (GERD)

    Not yet reported Eisai Inc. 1061 participants Est. completion 2010-01 88 sites Stand-alone
    Other conditions: Gastroesophageal Reflux Disease (GERD)
    View official trial listing →
  • Completed NCT NCT00658632

    Rabeprazole Extended-Release 50 mg Versus Esomeprazole 40 mg for Healing and Symptomatic Relief of Mild to Moderate Erosive Gastroesophageal Reflux Disease (GERD)

    Not yet reported Eisai Inc. 1397 participants Est. completion 2009-09 85 sites Stand-alone
    Other conditions: Gastroesophageal Reflux Disease (GERD)
    View official trial listing →
  • Completed NCT NCT00658775

    Rabeprazole Extended-Release, 50 mg, Versus Esomeprazole, 40 mg, for Healing and Symptomatic Relief of Moderate to Severe Erosive Gastroesophageal Reflux Disease (GERD)

    Not yet reported Eisai Inc. 1069 participants Est. completion 2010-01 83 sites Stand-alone
    Other conditions: Gastroesophageal Reflux Disease (GERD)
    View official trial listing →
  • Completed NCT NCT00681005

    A Comparative Study of Proton-pump Inhibitor Tests for Chinese Reflux Patients in Relation to the CYP2C19 Genotypes

    Not yet reported National Taiwan University Hospital 178 participants Est. completion 2008-01
    Other conditions: GERD
    View official trial listing →
  • Completed NCT NCT00747526

    A Study of Single and Multiple Doses of Rabeprazole in Pediatric Patients With Gastroesophageal Reflux Disease (GERD) 1 to 11 Months Old, Inclusive

    Not yet reported Janssen Research & Development, LLC 51 participants Est. completion 2012-02 20 sites Stand-alone
    Other conditions: Gastroesophageal Reflux Disease (GERD)
    View official trial listing →
  • Completed NCT NCT00747695

    A Pharmacokinetic and Safety Study of Single and Multiple Doses of Rabreprazole in Pediatric Patients With Gastroesophageal Reflux Disease (GERD) 1 to 11 Years Old, Inclusive

    Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 31 participants Est. completion 2009-09
    Other conditions: GERD
    View official trial listing →
  • Completed NCT NCT00770913

    Double-blind Comparative Study of E3810 Tablets (10 or 20 mg b.i.d.) to Evaluate Efficacy and Safety in Patients With Refractory Reflux Esophagitis

    Not yet reported, Not yet reported Eisai Co., Ltd. 337 participants Est. completion 2010-03 54 sites
    Other conditions: Refractory Reflux Esophagitis
    View official trial listing →
  • Completed NCT NCT00787891

    A Study of the Safety and Effectiveness of Rabeprazole for the Treatment of Gastroesophageal Reflux Disease (GERD) in Pediatric Patients

    Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 127 participants Est. completion 2011-01 Stand-alone
    Other conditions: Gastroesophageal Reflux Disease (GERD)
    View official trial listing →
  • Completed NCT NCT00838526

    Rabeprazole Extended-Release 50 mg vs. Ranitidine 150 mg for Maintenance of Healed Erosive Gastroesophageal Reflux Disease (GERD)

    Not yet reported Eisai Inc. 240 participants Est. completion 2009-12-31 4 sites Stand-alone
    Other conditions: Gastroesophageal Reflux Disease (GERD)
    View official trial listing →
  • Terminated NCT NCT00838682

    Effect of High-dose Oral Rabeprazole on Recurrent Bleeding After the Endoscopic Treatment of Bleeding Peptic Ulcers

    Not yet reported The Catholic University of Korea 106 participants Est. completion 2009-03 2 sites Stand-alone
    Other conditions: Peptic Ulcer Hemorrhage
    View official trial listing →
  • Completed NCT NCT00839306

    Rabeprazole Extended Release 50 mg Versus Ranitidine 150 mg for Maintenance of Healed Erosive Gastroesophageal Reflux Disease (GERD)

    Not yet reported Eisai Inc. 240 participants Est. completion 2010-01 4 sites Stand-alone
    Other conditions: Gastroesophageal Reflux Disease (GERD)
    View official trial listing →
  • Completed NCT NCT00844675

    Effects of Oral Rabeprazole on the Prevention of Ulcer Bleeding Following Endoscopic Mucosal Resection

    Not yet reported The Catholic University of Korea 120 participants Est. completion 2012-03 1 site Stand-alone
    Other conditions: Early Gastric Adenocarcinoma, Adenocarcinoma, Tubular
    View official trial listing →
  • Completed NCT NCT00855361

    A Pharmacokinetics, Pharmacodynamics and Safety Study of Rabeprazole in New Born Infants With Gastroesophageal Reflux Disease (GERD)

    Not yet reported Janssen Research & Development, LLC 69 participants Est. completion 2011-12 19 sites Stand-alone
    Other conditions: Gastroesophageal Reflux
    View official trial listing →
  • Terminated NCT NCT00857597

    Endoscopic Fundoplication Versus Proton Pump Inhibitors for GERD Treatment

    Not yet reported University of Pittsburgh 60 participants Est. completion 2011-12 1 site
    Other conditions: Gastroesophageal Reflux Disease (GERD)
    View official trial listing →
  • Status unknown NCT NCT00861640

    Comparison of Oral Rabeprazole vs. iv Omeprazole in Mild to Moderate Nonvariceal Upper Gastrointestinal Bleeding

    Not yet reported Kaohsiung Medical University Chung-Ho Memorial Hospital 200 participants Est. completion 2010-04 1 site Stand-alone
    Other conditions: Nonvariceal Upper Gastrointestinal Bleeding
    View official trial listing →
  • Completed NCT NCT00911534

    Comparing the Efficacy, Safety, and Tolerability of Rabeprazole ER 50 mg With Placebo in Subjects With Symptomatic Gastroesophageal Reflux Disease (sGERD)

    Not yet reported Eisai Inc. 305 participants Est. completion 2009-10 98 sites Stand-alone
    Other conditions: Symptomatic Gastroesophageal Reflux Disease (sGERD)
    View official trial listing →
  • Completed NCT NCT00978016

    A Study to Evaluate the Efficacy and Safety of Arbaclofen Placarbil (XP19986) as Adjunctive Therapy in Subjects With Gastroesophageal Reflux Disease (GERD)

    Not yet reported XenoPort, Inc. 460 participants Est. completion 2010-12 64 sites Stand-alone
    Other conditions: Gastroesophageal Reflux Disease
    View official trial listing →
  • Completed NCT NCT00989300

    Influence of Rabeprazole on the Magnitude of the Antiplatelet Action of Clopidogrel

    Not yet reported Janssen Cilag S.A.S. 39 participants Est. completion 2010-03 Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT00992589

    Safety and Efficacy of Rabeprazole in Infants With Gastroesophageal Erosive Reflux Disease (GERD)

    Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 344 participants Est. completion 2011-11 81 sites Stand-alone
    Other conditions: Gastroesophageal Reflux
    View official trial listing →
  • Completed NCT NCT00999128

    A Study to Determine the Relative Bioavailability of Capsule and Tablet Formulations of GDC-0941 and the Effect of Food and Proton Pump Inhibition on GDC-0941 Tablet Pharmacokinetics in Healthy Volunteers

    Not yet reported Genentech, Inc. 50 participants Est. completion 2010-02-26 1 site Stand-alone
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT01002443

    Efficacy Study of Helicobacter Pylori Eradication in Patients Undergoing Subtotal Gastrectomy for Gastric Cancer

    Not yet reported National Cancer Center, Korea 190 participants Est. completion 2009-03 1 site
    Other conditions: Gastric Cancer
    View official trial listing →
  • Completed NCT NCT01008696

    An Efficacy Study to Compare the Treatment Effects of Rabeprazole and Lansoprazole Depending on the Genotyping of CYP2C19 in Treating Reflux Esophagitis

    Not yet reported Janssen Korea, Ltd., Korea 217 participants Est. completion 2008-08 Stand-alone
    Other conditions: Reflux Esophagitis
    View official trial listing →
  • Completed NCT NCT01018160

    Practice and Patient Compliance on the PPI (Proton Pump Inhibitors) Treatment of Gastroesophageal Reflux in South Korea

    Janssen Korea, Ltd., Korea 1197 participants Est. completion 2009-02
    Other conditions: Gastroesophageal Reflux
    View official trial listing →
  • Status unknown NCT NCT01023360

    Evaluation of Antiplatelet Drug Resistance in Taiwanese With VASP & Platelet Mapping ™ Assay

    Not yet reported National Taiwan University Hospital 30 participants Est. completion 2010-10 1 site Stand-alone
    Other conditions: 30 Healthy People
    View official trial listing →
  • Status unknown NCT NCT01037491

    Comparison of Ulcer Healing in Patients Taking Rabeprazole With Different Antiplatelets

    Not yet reported Taipei Veterans General Hospital, Taiwan 200 participants Est. completion 2010-12 1 site
    Other conditions: Gastric Ulcer, Duodenal Ulcer
    View official trial listing →
  • Completed NCT NCT01051388

    Cardio-cerebrovascular Disease and Aspirin Ulcer Relapse Evaluation

    Not yet reported Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan 280 participants Est. completion 2010-12 1 site
    Other conditions: Cardio-cerebrovascular Disease
    View official trial listing →
  • Completed NCT NCT01085695

    Study of E3810 for Healthy Japanese Male (Under Fasting Condition)

    Not yet reported Eisai Co., Ltd. 16 participants Est. completion 2010-05 Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT01085708

    A Pilot Cross-over Bioequivalence Study of E3810 for Healthy Japanese Male (Under Postprandial Condition)

    Not yet reported Eisai Co., Ltd. 16 participants Est. completion 2010-05 Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT01089543

    A Study of E3810 for Japanese Subjects With Functional Dyspepsia (SAMURAI Study: Suppression of Acid Milieu With Rabeprazole Improving Functional Dyspepsia ) (Study E3810-J081-204)

    Not yet reported Eisai Co., Ltd. 338 participants Est. completion 2011-08 46 sites Stand-alone
    Other conditions: Functional Dyspepsia
    View official trial listing →
  • Completed NCT NCT01101646

    A Pharmacokinetic and Relative Bioavailability Study With Rabeprazole Sodium in Healthy Adult Volunteers

    Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 36 participants Est. completion 2008-09 1 site Stand-alone
    Other conditions: Gastroesophageal Reflux
    View official trial listing →
  • Completed NCT NCT01136317

    Comparison of Antisecretory Effect of a Single Dose of Rabeprazole 20 mg and Omeprazole 20 mg in Obese Subjects

    Not yet reported Nantes University Hospital Est. completion 2010-07 1 site Stand-alone
    Other conditions: Gastroesophageal Reflux
    View official trial listing →
  • Completed NCT NCT01139645

    The Effect of Proton Pump Inhibitors on Calcium and Bone Metabolism

    Not yet reported American University of Beirut Medical Center 58 participants Est. completion 2010-07 1 site Stand-alone
    Other conditions: Calcium Metabolism Disorders
    View official trial listing →
  • Completed NCT NCT01140828

    A Study of Rabeprazole for Prevention of Non Steroidal Anti-inflammatory Drug -Associated Gastroduodenal Injury

    Not yet reported Chinese University of Hong Kong 112 participants Est. completion 2015-06 1 site
    Osteoarthritis Other conditions: Arthritis, Rheumatoid, Dyspepsia
    View official trial listing →
  • Completed NCT NCT01153659

    A Study to Evaluate the Effect on 24-hour, Intragastric pH of RAB ER 50-mg Capsules Compared With Esomeprazole (Nexium) 40 mg Capsules and Rabeprazole (Aciphex) 20-mg Tablets

    Not yet reported Eisai Inc. 90 participants Est. completion 2010-10 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT01163435

    Efficacy of High Dose Dual Therapy, Sequential Therapy and Triple Therapy in H. Pylori Eradication

    Not yet reported National Taiwan University Hospital 618 participants Est. completion 2013-10 1 site Stand-alone
    Other conditions: Helicobacter Infection
    View official trial listing →
  • Completed NCT NCT01186497

    A Relative Bioavailability Study of Rabeprazole Sodium Administered With Different Dosing Vehicles in Healthy Adult Volunteers

    Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 35 participants Est. completion 2010-11 Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT01202071

    A Clinical Pharmacological Study of Rabeprazole Sodium in Japanese Healthy Adult Male Volunteers (Study E3810)

    Not yet reported Eisai Co., Ltd. 24 participants Est. completion 2010-12 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT01219764

    A Trial of Standard vs Half Dose Rabeprazole, Clarithromycin, Metronidazole and Amoxicillin in the Treatment of Helicobacter Pylori Infection

    Not yet reported American University of Beirut Medical Center 200 participants Est. completion 2013-03 1 site Stand-alone
    Other conditions: Helicobacter Infections
    View official trial listing →
  • Completed NCT NCT01237353

    Study of the Ability of Betaine Hydrochloride to Increase Stomach Acid in Healthy Volunteers

    Not yet reported University of California, San Francisco 6 participants Est. completion 2011-07 1 site Stand-alone
    Other conditions: Pharmacodynamic
    View official trial listing →
  • Completed NCT NCT01241409

    A Bioequivalence Study of 2 Formulations of Rabeprazole Sodium and Evaluation of the Effect of Food on Rabeprazole Sodium in Healthy Adult Volunteers

    Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 78 participants Est. completion 2010-12 Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Status unknown NCT NCT01249482

    Symptom Assessment for GERD Patients Receiving H. Pylori Eradication

    National Taiwan University Hospital 300 participants Est. completion 2012-08 1 site
    Other conditions: Gastroesophageal Reflux Disease
    View official trial listing →
  • Completed NCT NCT01249651

    To Assess the Efficacy of Esomeprazole 40 mg Once Daily in Subjects Who Still Had Heartburn After Receiving Rabeprazole

    Not yet reported AstraZeneca 101 participants Est. completion 2011-06 1 site
    Other conditions: Heartburn
    View official trial listing →
  • Completed NCT NCT01264822

    Prognostic Study of Gastric MALT Lymphoma After Eradication of Helicobacter Pylori

    Eisai Co., Ltd. 108 participants Est. completion 2016-11-17 42 sites
    Other conditions: Gastric Low-grade MALT Lymphoma With Helicobacter Pylori Positive
    View official trial listing →
  • Status unknown NCT NCT01265069

    Efficacy of 10-day Concomitant Regimen Versus High Dose Dual Therapy in Anti-Helicobacter Pylori Rescue Therapy

    Not yet reported National Taiwan University Hospital 204 participants Est. completion 2013-12 1 site Stand-alone
    Other conditions: Helicobacter Pylori Infection
    View official trial listing →
  • Completed NCT NCT01277718

    A Study to Evaluate the Effect of a Proton-Pump Inhibitor (Rabeprazole) on the Relative Bioavailability of Cobimetinib in Healthy Participants

    Not yet reported Genentech, Inc. 20 participants Est. completion 2011-02 Stand-alone
    Other conditions: Healthy Volunteer
    View official trial listing →
  • Completed NCT NCT01286194

    A Study to Investigate Use Patterns and Safety in Simulated Actual Over-the-counter (OTC) Use of Rabeprazole Sodium for the Treatment of Heartburn Symptoms

    Eisai Inc. 1500 participants Est. completion 2007-01 33 sites
    Other conditions: Frequent Heartburn
    View official trial listing →
  • Completed NCT NCT01287091

    A 3-Part Study to Determine the Relative Bioavailability of Capsule and Tablet Formulations of GDC-0980, the Effect of Food, and the Effect of Rabeprazole on the Pharmacokinetics of the Tablet

    Not yet reported Genentech, Inc. 46 participants Est. completion 2011-02-03 1 site Stand-alone
    Other conditions: Healthy Volunteer
    View official trial listing →
  • Completed NCT NCT01321567

    Quality of Life in New Treatable Therapy as Rabeprazole Option for Refractory Reflux Esophagitis

    Eisai Co., Ltd. 2157 participants Est. completion 2013-08-01 447 sites
    Other conditions: Refractory Reflux Esophagitis
    View official trial listing →
  • Withdrawn NCT NCT01391715

    Double-dose Rabeprazole Accelerates and Sustains the Control of Symptoms in Patients With NERD

    Not yet reported Inje University Est. completion 2012-12 1 site
    Other conditions: Gastroesophageal Reflux Disease
    View official trial listing →
  • Completed NCT NCT01397084

    To Assess the Efficacy of Esomeprazole 20mg Once Daily in Subjects Who Still Had Heartburn After Receiving Rabeprazole

    Not yet reported AstraZeneca 107 participants Est. completion 2012-01
    Other conditions: Gastroesophageal Reflux Disease, GERD, Reflux Esophagitis
    View official trial listing →
  • Completed NCT NCT01397448

    Prevention of Recurrent Gastric or Duodenal Ulcers Caused by Low-dose Aspirin With Rabeprazole (E3810) Treatment (Planetarium Study)

    Not yet reported, Not yet reported Eisai Co., Ltd. 472 participants Est. completion 2013-06 49 sites
    Other conditions: Gastric or Duodenal Ulcers Caused by Low-dose Aspirin
    View official trial listing →
  • Completed NCT NCT01398046

    Effects of Gastric pH on the Pharmacokinetics of Dasatinib

    Not yet reported University of California, San Francisco 10 participants Est. completion 2014-02 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT01398410

    Long-term Prevention of Recurrent Gastric or Duodenal Ulcers Caused by Low-dose Aspirin With Rabeprazole (E3810) Treatment (Planetarium Study)

    Not yet reported, Not yet reported Eisai Co., Ltd. 405 participants Est. completion 2014-02 50 sites Stand-alone
    Other conditions: Gastric Ulcers Duodenal Ulcers Caused by Low-dose Aspirin
    View official trial listing →
  • Completed NCT NCT01408186

    ASP (PPI_H2RA) Study-H2RA Versus PPI for the Prevention of Recurrent UGIB in High-risk Users of Low-dose ASA

    Not yet reported Chinese University of Hong Kong 264 participants Est. completion 2016-11 8 sites
    Other conditions: Upper Gastrointestinal Bleeding
    View official trial listing →
  • Completed NCT NCT01453036

    Clarithromycin Resistant Tailored Therapy

    Not yet reported Jin Il Kim 924 participants Est. completion 2012-06 1 site
    Other conditions: Peptic Ulcer, Helicobacter Pylori Infection
    View official trial listing →
  • Status unknown NCT NCT01504971

    Narrow-band Imaging, Autofluorescence Imaging and Gastroesophageal Reflux Disease

    Chinese PLA General Hospital 95 participants Est. completion 2016-12 1 site
    Other conditions: Gastroesophageal Reflux Disease
    View official trial listing →
  • Completed NCT NCT01513785

    New Dual Therapy for Primary Treatment of Helicobacter Pylori Infection：a Pilot Study

    Not yet reported Shanghai Jiao Tong University School of Medicine 40 participants Est. completion 2012-01 1 site
    Other conditions: Functional Dyspepsia
    View official trial listing →
  • Status unknown NCT NCT01566643

    Rabeprazole Based Sequential-Concommitant Hybrid Therapies for H. Pylori Infections

    Not yet reported Buddhist Tzu Chi General Hospital 231 participants Est. completion 2012-12 1 site Stand-alone
    Other conditions: Helicobacter Pylori Infection
    View official trial listing →
  • Status unknown NCT NCT01572597

    Increased Re-eradication Rate of Helicobacter Pylori by Adding N-acetylcystein or Metronidazole to the Triple Therapy

    Not yet reported Buddhist Tzu Chi General Hospital 120 participants Est. completion 2012-12 1 site Stand-alone
    Other conditions: Bacterial Infection Due to Helicobacter Pylori (H. Pylori)
    View official trial listing →
  • Completed NCT NCT01573975

    Comparison Between Ten Days Sequential Treatment and Traditional Three Combined Treatment of Helicobacter Pylori

    Not yet reported Buddhist Tzu Chi General Hospital 345 participants Est. completion 2011-05 1 site Stand-alone
    Other conditions: Helicobacter Pylori Infection
    View official trial listing →
  • Terminated NCT NCT01575899

    Efficacy of Seven-day Combined Rabeprazole Plus Levofloxacin Plus Augmentin for Eradication of Helicobacter Pylori

    Not yet reported Buddhist Tzu Chi General Hospital 208 participants Est. completion 2009-12 1 site Stand-alone
    Other conditions: Helicobacter Pylori Infection
    View official trial listing →
  • Terminated NCT NCT01643785

    Additive Effect of Endonase on Eradication Rate of Second Line Therapy for HP Infection

    Not yet reported Chuncheon Sacred Heart Hospital 30 participants Est. completion 2013-06 1 site Stand-alone
    Other conditions: Helicobacter Pylori Infection
    View official trial listing →
  • Completed NCT NCT01699113

    Effects of YF476 and Rabeprazole on Gastric Function

    Not yet reported Trio Medicines Ltd. 32 participants Est. completion 2007-06 1 site
    Other conditions: Hypergastrinaemia
    View official trial listing →
  • Completed NCT NCT01702506

    Evaluation Of The Potential Effect That The Administration Of Food Or Antacid Medication May Have In The Oral Absorption Of Dacomitinib (PF-00299804)

    Not yet reported Pfizer 24 participants Est. completion 2013-01 1 site Stand-alone
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT01759875

    Effects of Gastric pH on the Pharmacokinetics of Atazanavir

    Not yet reported University of California, San Francisco 8 participants Est. completion 2014-01 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT01772290

    A Drug-Drug Interaction Study of the Effect of Rabeprazole, Itraconazole or Fluconazole on the Pharmacokinetics of Vismodegib

    Not yet reported Genentech, Inc. 92 participants Est. completion 2013-05 2 sites Stand-alone
    Other conditions: Healthy Volunteer
    View official trial listing →
  • Completed NCT NCT01805934

    Quadruple Therapy Versus Dual Therapy as Rescue Regimens for Helicobacter Pylori Infection

    Not yet reported Shanghai Jiao Tong University School of Medicine 114 participants Est. completion 2013-02 1 site
    Other conditions: Rescue Therapy for Helicobacter Pylori
    View official trial listing →
  • Completed NCT NCT01809535

    Monthly Versus Biweekly Endoscopic Variceal Ligation for the Prevention of Esophageal Variceal Rebleeding

    Not yet reported Kaohsiung Veterans General Hospital. 70 participants Est. completion 2012-10 1 site Stand-alone
    Other conditions: Variceal Bleeding, Endoscopic Variceal Ligation
    View official trial listing →
  • Completed NCT NCT01857609

    Clinical Trial to Investigate the Effect of Proton Pump Inhibitor on the Pharmacokinetics and Pharmacodynamics of Metformin

    Not yet reported Seoul National University Hospital 24 participants Est. completion 2012-12 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT01860482

    The Study to Evaluate Efficacy and Safety of Newrabell® Tab.(Rabeprazole Sodium) 10mg b.i.d in Refractory GERD

    Not yet reported Chong Kun Dang Pharmaceutical 39 participants Est. completion 2015-05 2 sites
    Other conditions: Reflux Esophagitis
    View official trial listing →
  • Completed NCT NCT01907633

    An Observational Study to Assess the Risk of Out-of-Hospital Sudden Cardiac Death in Users of Domperidone, Users of Proton Pump Inhibitors, and Users of Metoclopramide

    Janssen Research & Development, LLC 15000 participants Est. completion 2013-12
    Substance use disorder
    View official trial listing →
  • Completed NCT NCT01918176

    Drug Interaction Study To Investigate The Potential Effect Of Proton Pump Inhibitor On The Pharmacokinetics Of Palbociclib (PD-0332991)

    Not yet reported Pfizer 26 participants Est. completion 2013-12 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT01922505

    Eradication Rates of Helicobacter Pylori and Its Affecting Factors

    Seoul National University Bundang Hospital 2500 participants Est. completion 2013-05 1 site
    Other conditions: Helicobacter Infections
    View official trial listing →
  • Status unknown NCT NCT01922765

    Concomitant Therapy of H. Pylori

    Not yet reported The Catholic University of Korea 540 participants Est. completion 2014-02 1 site Stand-alone
    Other conditions: Gastritis, Gastric Ulcer, and Duodenal Ulcer
    View official trial listing →
  • Completed NCT NCT01954043

    A Pharmacokinetics (PK) Study of the Effects Rabeprazole and Rifampin on Dabrafenib in Subjects With BRAF V600 Mutation Positive Tumors

    Not yet reported GlaxoSmithKline 23 participants Est. completion 2016-02-29 6 sites Stand-alone
    Other conditions: Cancer
    View official trial listing →
  • Completed NCT NCT01967329

    CANHelp Working Group Treatment Trials

    Not yet reported University of Alberta 338 participants Est. completion 2019-05 1 site
    Other conditions: Helicobacter Pylori Infection
    View official trial listing →
  • Completed NCT NCT01990378

    Bioequivalence Study of Torrent Pharmaceutical Ltd.'s Rabeprazole Sodium Delayed Release Tablets Under Fasted Conditions

    Not yet reported Torrent Pharmaceuticals Limited 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT01990586

    Bioequivalence Study of Torrent Pharmaceutical Ltd.'s Rabeprazole Sodium Delayed Release Tablets Under Fed Conditions

    Not yet reported Torrent Pharmaceuticals Limited 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02037477

    Phase 3 Study to Evaluate the Acid-Inhibitory Effect of Multiple Oral Doses of Vonoprazan (TAK-438)

    Not yet reported Takeda 20 participants Est. completion 2014-03 1 site Stand-alone
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT02097329

    Study Of Three Different Stomach Acid Reducing Agents When Given With Palbociclib (PD-0332991) And Food

    Not yet reported Pfizer 27 participants Est. completion 2014-06 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02135107

    A Double-blind Comparative Study of the Efficacy and Safety of E3810 10mg Once and Twice Daily in Maintenance Therapy for PPI Resistant Gastroesophageal Reflux Disease Patients

    Not yet reported Eisai Co., Ltd. 517 participants Est. completion 2016-06 61 sites Stand-alone
    Other conditions: Gastroesophageal Reflux Disease
    View official trial listing →
  • Status unknown NCT NCT02149914

    The Changes of Ryodoraku and HRV After PPI Treatment in GERD Patients

    Not yet reported Taichung Tzu Chi Hospital 120 participants Est. completion 2016-07 1 site
    Other conditions: Non-erosive Reflux Disease, Barrett's Esophagus
    View official trial listing →
  • Completed NCT NCT02311946

    A Pilot Study To Investigate The Effect Of Concurrent Antacid Administration On The Bioavailability Of Six Experimental Formulations Of Palbociclib

    Not yet reported Pfizer 60 participants Est. completion 2015-04 3 sites Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Status unknown NCT NCT02368470

    Randomized Study on Efficacy of Gemifloxacin-based Regimen for Helicobacter Pylori Infection

    Not yet reported Samsung Medical Center 252 participants Est. completion 2015-10 1 site Stand-alone
    Other conditions: Helicobacter Pylori Infection
    View official trial listing →
  • Active, not recruiting NCT NCT02407119

    Effects of H. Pylori Eradication on the Gastric Preneoplastic Lesion and Neoplasm After ESD

    Not yet reported National Cancer Center, Korea 470 participants Est. completion 2030-06 1 site
    Other conditions: Helicobacter Pylori Infection, Early Gastric Cancer, Endoscopic Resection
    View official trial listing →
  • Completed NCT NCT02423187

    Rabeprazole Specific Clinical Experience Investigation for the Long-term Combination Therapy With Low-dose Aspirin

    Eisai Co., Ltd. 1568 participants Est. completion 2017-10-30 3 sites
    Other conditions: Gastric Ulcer, Duodenal Ulcer
    View official trial listing →
  • Completed NCT NCT02446483

    A Bioequivalence Study of Idiazole 20mg DR Tabs and PARIET® 20 mg DR Tabs After a Single Oral Dose Administration Under Fasting Conditions in Healthy Adults

    Not yet reported GlaxoSmithKline 60 participants Est. completion 2014-03-26 1 site Stand-alone
    Other conditions: Gastrointestinal Diseases
    View official trial listing →
  • Completed NCT NCT02449941

    Helicobacter Pylori and Proton Pump Inhibitor

    Asan Medical Center 30 participants Est. completion 2016-12 1 site
    Other conditions: Helicobacter Infections
    View official trial listing →
  • Completed NCT NCT02463643

    To Evaluate Efficacy and Safety of Z-215 in Erosive Esophagitis

    Not yet reported Zeria Pharmaceutical 503 participants Est. completion 2017-03 1 site Stand-alone
    Other conditions: Esophagitis, Reflux
    View official trial listing →
  • Completed NCT NCT02475161

    A Study to Investigate the Effect of Increased Gastric pH on the Oral Bioavailability of the Orexin-2 Receptor Antagonist JNJ-42847922 in Healthy Participants

    Not yet reported Janssen Research & Development, LLC 16 participants Est. completion 2015-07 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02477306

    A Bioequivalence Study of Rabeprazole From Idiazole 20mg DR Tabs (GSK, Egypt) and PARIET 20 mg DR Tabs (JANSSEN, EGYPT)

    Not yet reported Genuine Research Center, Egypt 60 participants Est. completion 2014-03 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02483715

    Efficacy of High-dose Dual Therapy vs Bismuth-containing Quadruple Therapy for First-line Treatment of Hp Infection

    Not yet reported National Taiwan University Hospital 589 participants Est. completion 2018-05 1 site Stand-alone
    Other conditions: Helicobacter Pylori Infection
    View official trial listing →
  • Completed NCT NCT02490839

    Efficacy of High-dose Dual Therapy vs Bismuth-containing Quadruple Therapy for Rescue Treatment of Hp Infection

    Not yet reported National Taiwan University Hospital 450 participants Est. completion 2019-01 1 site Stand-alone
    Other conditions: Helicobacter Pylori Infection
    View official trial listing →
  • Completed NCT NCT02509923

    To Evaluate Pharmacokinetics and Pharmacodynamics of Z-215 in Healthy Male Subjects

    Not yet reported Zeria Pharmaceutical 54 participants Est. completion 2016-09 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02524210

    Effect of Inhibitors of the Proton Pump on Intestinal Transporters

    Not yet reported Centre Hospitalier Universitaire de Saint Etienne 12 participants Est. completion 2015-12 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02541786

    Comparison of Dexlansoprazole-based Triple and Rabeprazole-based Triple Therapies for Helicobacter Pylori Infection

    Not yet reported Kaohsiung Medical University 177 participants Est. completion 2015-08 2 sites Stand-alone
    Other conditions: Helicobacter Pylori Infection
    View official trial listing →
  • Completed NCT NCT02547025

    Personalized Treatment for Refractory H Pylori Infection

    Not yet reported Kaohsiung Veterans General Hospital. 126 participants Est. completion 2021-10-31 1 site Stand-alone
    Other conditions: Helicobacter Pylori Infection
    View official trial listing →
  • Completed NCT NCT02555852

    Proton Pump Inhibitors and Risk of Community-acquired Pneumonia

    Canadian Network for Observational Drug Effect Studies, CNODES 4238504 participants Est. completion 2012-02 1 site
    Other conditions: Gastroesophageal Reflux Disease (GERD), Community-acquired Pneumonia
    View official trial listing →
  • Completed NCT NCT02569554

    PPI And Food Effect Study For PF-06463922 In Healthy Volunteers

    Not yet reported Pfizer 27 participants Est. completion 2016-04 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02605395

    Bioequivalence Study of Raperazole 20mg DR Tabs and PARIET® 20 mg DR Tabs Under Fed Conditions

    Not yet reported GlaxoSmithKline 70 participants Est. completion 2014-03-30 1 site Stand-alone
    Other conditions: Gastrointestinal Diseases
    View official trial listing →
  • Status unknown NCT NCT02635191

    Tailored Therapy for Helicobacter Pylori in Children

    Not yet reported Beijing Children's Hospital 200 participants Est. completion 2016-07 1 site
    Other conditions: Helicobacter Pylori Infection
    View official trial listing →
  • Completed NCT NCT02637557

    A Trial of IW-3718 for 8 Weeks in Patients With Symptomatic Gastroesophageal Reflux Disease (GERD)

    Not yet reported Ironwood Pharmaceuticals, Inc. 282 participants Est. completion 2017-04-26 62 sites Stand-alone
    Other conditions: Gastroesophageal Reflux Disease
    View official trial listing →
  • Completed NCT NCT02638584

    Effects of Ilaprazole on Ulcer Healing Rate and Prevention of Gastrointestinal Bleeding in the Patients Undergone ESD.

    Not yet reported Il-Yang Pharm. Co., Ltd. 176 participants Est. completion 2018-03 1 site
    Other conditions: Gastric Cancer
    View official trial listing →
  • Completed NCT NCT02655614

    A Study of GDC-0134 to Determine Initial Safety, Tolerability, and Pharmacokinetic Parameters in Participants With Amyotrophic Lateral Sclerosis

    Not yet reported Genentech, Inc. 54 participants Est. completion 2020-03-16 10 sites Stand-alone
    Other conditions: Amyotrophic Lateral Sclerosis
    View official trial listing →
  • Completed NCT NCT02689999

    The Effect of Dexrabeprazole on Intragastric and Intraesophageal Acidity

    Not yet reported Neutec Ar-Ge San ve Tic A.Ş 12 participants Est. completion 2017-08 3 sites
    Other conditions: Gastroesophageal Reflux Disease (GERD)
    View official trial listing →
  • Completed NCT NCT02699710

    Effect of Food, Rabeprazole, Methotrexate and Formulation on the Pharmacokinetics (PK) of GDC-0853 and the Effect of GDC-0853 on the PK of Methotrexate in Healthy Subjects

    Not yet reported Genentech, Inc. 50 participants Est. completion 2016-05-26 1 site Stand-alone
    Other conditions: Healthy Volunteer
    View official trial listing →
  • Completed NCT NCT02703896

    Prophylaxis for Aspiration of Gastric Contents.

    Not yet reported King Saud University 1920 participants Est. completion 2015-12
    Other conditions: Pulmonary Aspiration of Gastric Contents
    View official trial listing →
  • Withdrawn NCT NCT02747797

    Lucitanib (E3810) in Patients With Advanced Cancer and FGFR, VEGFR, or PDGFR Pathway Aberrations

    Not yet reported Teresa Helsten, MD Est. completion 2022-04 1 site
    Other conditions: Advanced Cancer
    View official trial listing →
  • Completed NCT NCT02767479

    Comparison of Rabeprazole and Esomperazole for the Eradication of H. Pylori

    Not yet reported Hamamatsu University 200 participants Est. completion 2016-04 1 site
    Other conditions: H. Pylori Infection
    View official trial listing →
  • Completed NCT NCT02776371

    Modified Non-clarithromycin Triple Therapy in Eradicating Helicobacter Pylori

    Not yet reported Shandong University 301 participants Est. completion 2018-02 1 site Stand-alone
    Other conditions: Helicobacter Pylori Eradication Rate
    View official trial listing →
  • Completed NCT NCT02826408

    Effect of Proton Pump Inhibitors on Palpitations

    Not yet reported Jordan Collaborating Cardiology Group 30 participants Est. completion 2018-03 1 site
    Other conditions: Signs and Symptoms
    View official trial listing →
  • Completed NCT NCT02847455

    Ilaprazole for the Treatment of Duodenal Ulcer in Chinese Patients

    Not yet reported, Not yet reported Livzon Pharmaceutical Group Inc. 408 participants
    Other conditions: Duodenal Ulcer
    View official trial listing →
  • Status unknown NCT NCT02934152

    Symptom Assessment for Patients With Gastro-esophageal Reflux Disease Receiving Helicobacter Pylori Eradication

    Not yet reported National Taiwan University Hospital 400 participants Est. completion 2019-09 1 site Stand-alone
    Other conditions: Gastroesophageal Reflux Disease
    View official trial listing →
  • Withdrawn NCT NCT02986685

    Trimebutine Maleate Combined With Rabeprazole in Patients With Grade A or B Reflux Esophagitis Whose Symptoms Refractory to Rabeprazole

    Not yet reported Xijing Hospital of Digestive Diseases Est. completion 2017-11 1 site Stand-alone
    Other conditions: Refractory Reflux Esophagitis
    View official trial listing →
  • Completed NCT NCT03037606

    Comparison of the Effect of Rabeprazole 50 mg DDR Capsules and 20 mg Enteric-coated Tablets

    Not yet reported Neutec Ar-Ge San ve Tic A.Ş 48 participants Est. completion 2018-12-11 1 site
    Other conditions: Gastroesophageal Reflux Disease
    View official trial listing →
  • Completed NCT NCT03094416

    Levothyroxine Sodium in Thyroidectomized Patients Taking Proton Pump Inhibitors

    Not yet reported IBSA Institut Biochimique SA 66 participants Est. completion 2020-06-15 9 sites
    Other conditions: Hypothyroidism;Postablative
    View official trial listing →
  • Completed NCT NCT03108287

    Adding Bismuth to Rabeprazole-based First-line Triple Therapy Does Not Improve the Eradication of Helicobacter Pylori

    Not yet reported Kaohsiung Medical University Chung-Ho Memorial Hospital 162 participants Est. completion 2015-02-28
    Other conditions: Helicobacter Pylori Infection
    View official trial listing →
  • Completed NCT NCT03117101

    Study of the AL3810 in the Treatment of Advanced Solid Tumor

    Not yet reported Haihe Biopharma Co., Ltd. 17 participants Est. completion 2016-09 1 site
    Other conditions: Advanced Solid Tumors
    View official trial listing →
  • Completed NCT NCT03130556

    A Study Of Glasdegib In Healthy Volunteers To Establish The Bioequivalence Of The Phase 2 Formulation To The ICH Formulation

    Not yet reported Pfizer 24 participants Est. completion 2017-07-21 1 site Stand-alone
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Status unknown NCT NCT03134378

    10 vs 14 Days Triple Therapy : H.Pylori Infection Eradication

    Not yet reported Indonesia University 73 participants Est. completion 2017-05-12 1 site Stand-alone
    Other conditions: Helicobacter Pylori Infection
    View official trial listing →
  • Completed NCT NCT03143166

    Pradaxa Tablet Proton Pump Inhibitor (PPI) Bioavailability (BA) Study in Japan

    Not yet reported Boehringer Ingelheim 36 participants Est. completion 2017-08-02 1 site Stand-alone
    Other conditions: Non-alcoholic Fatty Liver Disease
    View official trial listing →
  • Completed NCT NCT03220191

    Proton Pump Inhibitor (PPI, Rabeprazole) Effect On Tablet Formulation Of Palbociclib

    Not yet reported Pfizer 12 participants Est. completion 2017-09-26 1 site Stand-alone
    Other conditions: Healthy Volunteer
    View official trial listing →
  • Completed NCT NCT03237741

    Bioavailability of GDC-0134 and the Effect of Food and Proton Pump Inhibitor on Pharmacokinetics of GDC-0134 in Healthy Female Participants

    Not yet reported Genentech, Inc. 18 participants Est. completion 2017-12-14 1 site Stand-alone
    Other conditions: Amyotrophic Lateral Sclerosis
    View official trial listing →
  • Status unknown NCT NCT03260179

    Study to Evaluate the Safety, Preliminary Efficacy and Pharmacokinetics of 3810

    Not yet reported Haihe Biopharma Co., Ltd. 60 participants Est. completion 2019-06-30 7 sites
    Other conditions: Advanced Solid Tumor, Advanced/Metastatic Colorectal Cancer
    View official trial listing →
  • Completed NCT NCT03290703

    A Study to Investigate the Effect of Formulation, Food, and Rabeprazole on the Pharmacokinetics (PK) of GDC-0853 in Healthy Participants

    Not yet reported Genentech, Inc. 63 participants Est. completion 2018-10-25 1 site Stand-alone
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT03320538

    Efficacy and Safety of Hou Gu Mi Xi in Patients With Peptic Ulcer Diseases

    Not yet reported Jiangxi University of Traditional Chinese Medicine 360 participants Est. completion 2020-09-17 1 site Stand-alone
    Other conditions: Peptic Ulcer Disease
    View official trial listing →
  • Status unknown NCT NCT03361267

    Comparison of Bismuth Containing Quadruple Therapy and Based Tailored Therapy for H. Pylori Infection

    Not yet reported Inha University Hospital 300 participants Est. completion 2018-06-28 1 site Stand-alone
    Other conditions: Helicobacter Pylori Infection, Compliance, Patient, Drug Resistance, Antibiotics
    View official trial listing →
  • Status unknown NCT NCT03397680

    Effectiveness of Once-daily Dose Regimen of 7-day and 14-day High Dose Rabeprazole-levofloxacin Based Quadruple Therapy for H. Pylori Eradication in Thai Patients With Non-ulcer Dyspepsia

    Not yet reported Thammasat University 100 participants Est. completion 2018-05-15 1 site
    Other conditions: Helicobacter Pylori Infection
    View official trial listing →
  • Completed NCT NCT03464058

    Study to Determine the Single and Repeat Dose Pharmacokinetics, Food Effect, Proton Pump Inhibitor (PPI) Drug Interaction, Safety and Tolerability of Oral Prototype Formulations of BOS172767 in Healthy Subjects

    Not yet reported Boston Pharmaceuticals 28 participants Est. completion 2018-10-10 1 site Stand-alone
    Other conditions: Healthy Subjects
    View official trial listing →
  • Completed NCT NCT03521726

    Intraluminal Amoxicillin Powder Monotherapy for Helicobacter Pylori Infection

    Not yet reported Mackay Memorial Hospital 20 participants Est. completion 2019-02-12 1 site
    Other conditions: Helicobacter Pylori Infection
    View official trial listing →
  • Completed NCT NCT03530995

    Drug-drug Interaction Between Belumosudil, Itraconazole, Rifampicin, Rabeprazole, and Omeprazole in Healthy Volunteers

    Not yet reported Kadmon Corporation, LLC 73 participants Est. completion 2019-02-08 1 site Stand-alone
    Other conditions: Drug-drug Interaction, Autoimmune Diseases, Fibrotic Disease
    View official trial listing →
  • Status unknown NCT NCT03565484

    Antimicrobial Susceptibility Testing Guided Therapy Versus Empirical Therapy for the Rescue Treatment of Helicobacter Pylori Infection

    Not yet reported Shandong University 400 participants Est. completion 2020-06-30 1 site Stand-alone
    Other conditions: Helicobacter Pylori Infection
    View official trial listing →
  • Status unknown NCT NCT03600974

    A New System for GERD Diagnosis and Treatment

    Capital Medical University 200 participants Est. completion 2021-07-01
    Other conditions: GERD
    View official trial listing →
  • Status unknown NCT NCT03616405

    Pilot Study of a 14-day Modified Sequential Therapy for Helicobacter Pylori Infection

    Not yet reported Shandong University 60 participants Est. completion 2020-04-30 1 site Stand-alone
    Other conditions: Helicobacter Pylori Infection
    View official trial listing →
  • Completed NCT NCT03658473

    Evaluation of Rebamipide and Rabeprazole Effect Associated or Not to Prevent Naproxen-induced Gastric Lesions

    Not yet reported Galeno Desenvolvimento de Pesquisas Clínicas 32 participants Est. completion 2015-02-04 1 site
    Other conditions: Gastric Lesion
    View official trial listing →
  • Status unknown NCT NCT03658733

    A Pilot Study of a 14-day Modified Sequential Therapy for Helicobacter Pylori Infection

    Not yet reported Shandong University 120 participants Est. completion 2019-10-31 1 site
    Other conditions: Helicobacter Pylori Infection
    View official trial listing →
  • Completed NCT NCT03658746

    Efficacies of Antimicrobial Susceptibility-Guided Versus Empirical Therapy for Rescue Treatment of Helicobacter Pylori Infection

    Not yet reported Shandong University 420 participants Est. completion 2019-12-31 1 site Stand-alone
    Other conditions: Helicobacter Pylori Infection
    View official trial listing →
  • Completed NCT NCT03779074

    Comparing the Efficacy of Hybrid, High-dose Dual and Bismuth Quadruple Therapies

    Not yet reported Kaohsiung Veterans General Hospital. 918 participants Est. completion 2021-12-31 1 site Stand-alone
    Other conditions: Helicobacter Pylori Infection
    View official trial listing →
  • Completed NCT NCT03789032

    Study to Evaluate the Effect of Rabeprazole on the Pharmacokinetics of Vadadustat

    Not yet reported Akebia Therapeutics 20 participants Est. completion 2018-11-19 1 site Stand-alone
    Other conditions: Drug Interaction Potentiation, Pharmacokinetics
    View official trial listing →
  • Status unknown NCT NCT03802318

    Daily Four Times or Two Times Usage of PPI and Amoxicillin for the First or Second Line H. Pylori Eradication

    Not yet reported Chang Gung Memorial Hospital 530 participants Est. completion 2020-12 1 site Stand-alone
    Other conditions: Helicobacter Pylori Infection, Helicobacter Gastritis, Helicobacter-Associated Pyloric Ulcer
    View official trial listing →
  • Completed NCT NCT03897244

    Efficacies of HDDT With or Without Bismuth vs Amoxicillin-metronidazole BQT for First-line H Pylori Eradication

    Not yet reported National Taiwan University Hospital 603 participants Est. completion 2025-02-17 1 site Stand-alone
    Other conditions: Helicobacter Pylori Infection
    View official trial listing →
  • Status unknown NCT NCT03908619

    A RCT of Triple Therapy With Proton Pump Inhibitor vs Vonoprazan for Helicobacter Pylori Gastritis

    Not yet reported Changi General Hospital 252 participants Est. completion 2021-03-31 1 site
    Other conditions: Helicobacter Pylori Infection
    View official trial listing →
  • Completed NCT NCT03979248

    A Study to Investigate the Effects of Gastric Acid Suppression by Rabeprazole and BMS-986165 on How Fast and Complete The Drug is Absorbed Into the Body of Healthy Participants

    Not yet reported Bristol-Myers Squibb 21 participants Est. completion 2019-07-07 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Status unknown NCT NCT03997279

    Assesment of the Efficiency and Safety Helicobacter Pylori Therapy With or Without Saccharomyces Boulardii

    Not yet reported Clinical Centre of Serbia 200 participants Est. completion 2020-06 Stand-alone
    Other conditions: Helicobacter Pylori Infection
    View official trial listing →
  • Completed NCT NCT04001400

    Treatment Response of High-dose and Standard-dose Rabeprazole for Extra-esophageal Reflux.

    Not yet reported Seoul National University Hospital 73 participants Est. completion 2014-05-21 1 site Stand-alone
    Other conditions: Esophageal Disease
    View official trial listing →
  • Completed NCT NCT04061447

    Tailored Juice-guided Eradication Therapy

    Not yet reported Kaohsiung Medical University 182 participants Est. completion 2019-07-31 1 site Stand-alone
    Other conditions: Helicobacter Pylori Infection
    View official trial listing →
  • Completed NCT NCT04132479

    The Epidemiology and Optimal Treatment of Helicobacter Pylori in Myanmar

    Not yet reported Kirby Institute 313 participants Est. completion 2019-04-09 1 site Stand-alone
    Other conditions: Helicobacter Pylori Infection
    View official trial listing →
  • Terminated NCT NCT04140591

    Proton Pump Inhibitor Plus Propranolol Versus Proton Pump Inhibitor Alone on Peptic Ulcer Healing in Patients With Liver Cirrhosis

    Not yet reported, Not yet reported Taipei Veterans General Hospital, Taiwan 10 participants Est. completion 2019-12-31 1 site
    Other conditions: Liver Cirrhosis, Peptic Ulcer
    View official trial listing →
  • Completed NCT NCT04157881

    A Study on the Impact of Rabeprazole-induced Elevated Stomach pH on APO-Dabigatran Exposure in Healthy Volunteers

    Not yet reported Population Health Research Institute 46 participants Est. completion 2022-01-18 1 site
    Other conditions: Atrial Fibrillation, Venous Thromboembolism
    View official trial listing →
  • Completed NCT NCT04209933

    Helicobacter Pylori Eradication With Different Bismuth Quadruple Therapies

    Not yet reported Xijing Hospital of Digestive Diseases 240 participants Est. completion 2020-08-30 1 site
    Other conditions: Gastric Cancer, Helicobacter Pylori Infection, Bismuth
    View official trial listing →
  • Completed NCT NCT04211545

    Relative Bioavailability and PPI Effects of CC-92480 Test and Reference Formulations in Healthy Subjects

    Not yet reported Celgene 24 participants Est. completion 2019-12-26 1 site Stand-alone
    Other conditions: Healthy Volunteer
    View official trial listing →
  • Status unknown NCT NCT04215653

    A Phase 3 Randomised Controlled Trial to Evaluate Efficacy and Safety of Anaprazole in Patients With Duodenal Ulcers.

    Not yet reported Sihuan Pharmaceutical Holdings Group Ltd. 448 participants Est. completion 2021-02-28 Stand-alone
    Other conditions: Duodenal Ulcer，DU
    View official trial listing →
  • Status unknown NCT NCT04254471

    This Phase II/III, Multicenter Study is Designed to Evaluate the Safety and Clinical Activity of AL3810 in Patients

    Not yet reported, Not yet reported Haihe Biopharma Co., Ltd. 313 participants Est. completion 2022-11-22 1 site
    Other conditions: Extensive-stage Small Cell Lung Cancer
    View official trial listing →
  • Completed NCT NCT04435483

    A Study of Acalabrutinib Suspension to Evaluate Relative Bioavailability and Proton-pump Inhibitor Effect in Healthy Volunteers

    Not yet reported AstraZeneca 39 participants Est. completion 2020-06-26 1 site Stand-alone
    Other conditions: Pharmacokinetics, Bioavailability
    View official trial listing →
  • Completed NCT NCT04471922

    A Multiple Ascending High Dose Pharmacology Study of Anaprazole in Healthy Chinese Subjects

    Not yet reported Sihuan Pharmaceutical Holdings Group Ltd. 45 participants Est. completion 2019-03-28 1 site
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT04488016

    A Study to Evaluate Relative Bioavailability, Proton Pump Inhibitor (PPI) (Rabeprazole) Effect, Food Effect and Particle Size Effect of New Acalabrutinib Tablet in Healthy Subjects

    Not yet reported AstraZeneca 54 participants Est. completion 2021-01-20 1 site Stand-alone
    Other conditions: Bioavailability, B-cell Lymphoid Cancer
    View official trial listing →
  • Completed NCT NCT04489797

    A Study to Evaluate Effects of Proton-pump Inhibitor on Acalabrutinib Capsule When Administered Orally With COCA-COLA in Healthy Participants

    Not yet reported AstraZeneca 35 participants Est. completion 2020-08-28 1 site Stand-alone
    Other conditions: Infectious Disease
    View official trial listing →
  • Completed NCT NCT04494243

    A Study to Compare PK, PD and Safety of the AD-214 10/600mg and Rabeprazole

    Not yet reported Addpharma Inc. 40 participants Est. completion 2021-01-15 1 site Stand-alone
    Other conditions: Gastroesophageal Reflux Disease
    View official trial listing →
  • Completed NCT NCT04503629

    A Phase 2 Randomised Controlled Trial to Evaluate Efficacy and Safety of Anaprazole in Patients With Duodenal Ulcers.

    Not yet reported Sihuan Pharmaceutical Holdings Group Ltd. 150 participants Est. completion 2019-05-17 1 site
    Other conditions: Duodenal Ulcer，DU
    View official trial listing →
  • Completed NCT NCT04510649

    Surufatinib DDI With a PPI and a CYP3A Inducer

    Not yet reported Hutchison Medipharma Limited 28 participants Est. completion 2021-03-02 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT04564040

    A Study in Healthy Subjects to Assess Bioavailability (Proportion of a Drug Which Enters the Circulation to Have an Active Effect) of Acalabrutinib Tablet and Protonpump Inhibitor Effect (Members of a Class of Medications That Inhibits in Gastric Acid Production) for Rabeprazole

    Not yet reported AstraZeneca 20 participants Est. completion 2020-12-11 1 site Stand-alone
    Other conditions: Mantle Cell Lymphoma, COVID-19
    View official trial listing →
  • Completed NCT NCT04564612

    Study of BIIB091 Formulations in Healthy Participants

    Not yet reported Biogen 59 participants Est. completion 2022-09-07 1 site Stand-alone
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT04565574

    A Study to Assess the Effect of Food Intake and Drug-drug Interactions of E7090 When Co-administered With Rabeprazole or Rifampin in Healthy Participants

    Not yet reported Eisai Co., Ltd. 42 participants Est. completion 2021-03-31 1 site Stand-alone
    Other conditions: Healthy Participants
    View official trial listing →
  • Completed NCT NCT04622358

    A Study to Compare PK, PD and Safety of the AD-214-02 and Rabeprazole

    Not yet reported Addpharma Inc. 43 participants Est. completion 2021-03-08 1 site Stand-alone
    Other conditions: Gastroesophageal Reflux Disease
    View official trial listing →
  • Completed NCT NCT04645940

    Fruquintinib Food Effect and Proton Pump Inhibitor Study

    Not yet reported Hutchison Medipharma Limited 14 participants Est. completion 2020-11-18 1 site Stand-alone
    Other conditions: Drug Interaction, Food-drug Interaction
    View official trial listing →
  • Completed NCT NCT04660123

    A Real World Study of Bismuth Colloidal Pectin Granules Quadruple Therapy for H. Pylori Eradication

    Not yet reported Xijing Hospital of Digestive Diseases 959 participants Est. completion 2021-12-30 1 site Stand-alone
    Other conditions: Gastric Cancer, Helicobacter Pylori Infection, Bismuth
    View official trial listing →
  • Status unknown NCT NCT04667299

    Bismuth-Metronidazole Triple Therapy for H. Pylori First-line Treatment

    Not yet reported Shanghai Zhongshan Hospital 270 participants Est. completion 2021-12-31 1 site Stand-alone
    Other conditions: Helicobacter Pylori Infection
    View official trial listing →
  • Completed NCT NCT04697186

    Helicobacter Pylori Eradication With Berberine Plus Amoxicillin Triple Therapy Versus Bismuth-containing Quadruple Therapy

    Not yet reported Xijing Hospital of Digestive Diseases 524 participants Est. completion 2021-12-20 1 site Stand-alone
    Other conditions: Dyspepsia, Chronic Gastritis, Gastric Cancer, Helicobacter Pylori Infection
    View official trial listing →
  • Completed NCT NCT04703868

    A Study to Compare the Safety, Pharmacokinetics and Pharmacodynamics of YPI 011 to Rabeprazole in Healthy Adult Subjects

    Not yet reported Yungjin Pharm. Co., Ltd. 88 participants Est. completion 2021-06-14 1 site Stand-alone
    Other conditions: Gastroesophageal Reflux Disease
    View official trial listing →
  • Suspended NCT NCT04723472

    Bismuth Quadruple Therapy With Cefuroxime for Helicobacter Pylori Eradication Treatment

    Not yet reported Shanghai East Hospital 82 participants Est. completion 2025-12-31 1 site Stand-alone
    Other conditions: Helicobacter Pylori Infection
    View official trial listing →
  • Completed NCT NCT04834752

    Effect of H2 Receptor Antagonist and Proton Pump Inhibitor on the Positivity Rates and Clinical Outcomes of COVID-19

    Seoul National University Hospital 400000 participants Est. completion 2021-12-31 1 site
    Other conditions: COVID-19
    View official trial listing →
  • Completed NCT NCT04923113

    Comparison of Different Helicobacter Pylori Detection Methods in Patients With Chronic Atrophic Gastritis

    Not yet reported Second Affiliated Hospital, Zhejiang University, School of Medicine 281 participants Est. completion 2023-01-18 2 sites Stand-alone
    Other conditions: Helicobacter Pylori Infection
    View official trial listing →
  • Completed NCT NCT04944771

    Study to Assess the Effect of Food and Acid Reducing Agents on the Absorption of Capivasertib in Healthy Participants

    Not yet reported AstraZeneca 48 participants Est. completion 2022-05-04 1 site Stand-alone
    Other conditions: Solid and Hematological Malignancies
    View official trial listing →
  • Completed NCT NCT05014334

    Study on The Efficacy and Safety of Berberine-containing Triple Therapy in Helicobacter Pylori First-Line Eradication

    Not yet reported Xijing Hospital of Digestive Diseases 300 participants Est. completion 2022-06-30 1 site
    Other conditions: Helicobacter Pylori Infection, Chronic Gastritis
    View official trial listing →
  • Status unknown NCT NCT05014685

    PPI-amoxicillin for H. Pylori Treatment

    Not yet reported Shanghai Zhongshan Hospital 732 participants Est. completion 2022-12-30 1 site Stand-alone
    Other conditions: Helicobacter Pylori Infection
    View official trial listing →
  • Status unknown NCT NCT05018923

    Tetracycline Versus Doxycycline for HP Rescue Therapy

    Not yet reported Shanghai Zhongshan Hospital 242 participants Est. completion 2022-12-30 1 site Stand-alone
    Other conditions: Helicobacter Pylori Infection
    View official trial listing →
  • Status unknown NCT NCT05023577

    Antibiotic Combination for H. Pylori Eradication in Penicillin-allergic Patients

    Not yet reported Shanghai Zhongshan Hospital 504 participants Est. completion 2022-12-30 1 site Stand-alone
    Other conditions: Helicobacter Pylori Infection
    View official trial listing →
  • Status unknown NCT NCT05061732

    Helicobacter Pylori Eradication and Follow-up

    Not yet reported Shanghai Zhongshan Hospital 4447 participants Est. completion 2026-06-30 1 site Stand-alone
    Other conditions: Helicobacter Pylori Infection
    View official trial listing →
  • Completed NCT NCT05152004

    Efficacies of Hybrid and High-dose Dual Therapies for the First-line Anti-H Pylori Treatment

    Not yet reported Chang Gung Memorial Hospital 240 participants Est. completion 2022-02-28 1 site Stand-alone
    Other conditions: Helicobacter Pylori Infection
    View official trial listing →
  • Status unknown NCT NCT05191888

    14-day PCAB-based High-dose Dual Therapy and14-day PCAB-based Triple Therapy vs 14-day PPI-based Reverse Hybrid Therapy

    Not yet reported Kaohsiung Medical University 906 participants Est. completion 2024-12-31 1 site
    Other conditions: Helicobacter Pylori Eradication
    View official trial listing →
  • Completed NCT NCT05208268

    A Study of Pariet to Prevent Gastric and Duodenal Ulcer Associated With Low-aspirin in Korean Participants With a History of Gastric and Duodenal Ulcer

    Eisai Korea Inc. 676 participants Est. completion 2022-09-22 29 sites
    Other conditions: Stomach Ulcer, Duodenal Ulcer
    View official trial listing →
  • Status unknown NCT NCT05226819

    Influencing Factors of Helicobacter Pylori Infection and Eradication Failure

    Not yet reported Second Affiliated Hospital of Xi'an Jiaotong University 300 participants Est. completion 2023-03 1 site
    Other conditions: Helicobacter Pylori Infection
    View official trial listing →
  • Status unknown NCT NCT05320133

    Jinghua Weikang Capsule Containing Quadruple Therapy for IgAN With Helicobacter Pylori Infection

    Not yet reported Peking University First Hospital 80 participants Est. completion 2024-12-31 1 site Stand-alone
    Other conditions: Helicobacter Pylori Infection
    View official trial listing →
  • Completed NCT NCT05330858

    Relative Bioavailability of ESK-001 Tablet Versus Liquid in Healthy Participants

    Not yet reported Alumis Inc 14 participants Est. completion 2022-09-20 1 site Stand-alone
    Other conditions: Pharmacokinetics
    View official trial listing →
  • Status unknown NCT NCT05364619

    Qingre Huashi Granules Combined the Modified Dual Therapy for Helicobacter Pylori Infection

    Not yet reported Peking University First Hospital 160 participants Est. completion 2024-12-31 3 sites Stand-alone
    Other conditions: Helicobacter Pylori Infection
    View official trial listing →
  • Completed NCT NCT05380947

    A Study in Healthy Men to Compare Two Different Oral Formulations of BI 1810631 and to Test How Food or Rabeprazole Influence the Amount of BI 1810631 in the Blood

    Not yet reported Boehringer Ingelheim 13 participants Est. completion 2022-09-13 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT05407675

    A Study to Evaluate the Safety and Tolerability of BMS-986408 Alone and in Combination With Nivolumab or Nivolumab and Ipilimumab in Participants With Advanced Solid Tumors

    Not yet reported, Not yet reported Bristol-Myers Squibb 68 participants Est. completion 2025-07-24 18 sites Stand-alone
    Other conditions: Advanced Solid Tumors
    View official trial listing →
  • Status unknown NCT NCT05419674

    Efficacy and Safety of Dual Therapy as First-line Treatment for Hp Infection

    Not yet reported Second Affiliated Hospital, Zhejiang University, School of Medicine 393 participants Est. completion 2023-08-01 1 site Stand-alone
    Other conditions: Helicobacter Pylori Infection
    View official trial listing →
  • Completed NCT NCT05446142

    A Relative Bioavailability Study Evaluating Two New Encorafenib Formulations

    Not yet reported Pfizer 18 participants Est. completion 2022-09-30 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT05571787

    HMPL-523 Food Effect and Proton Pump Inhibitor Study

    Not yet reported Hutchmed 26 participants Est. completion 2022-09-22 1 site Stand-alone
    Other conditions: Relapsed or Refractory Lymphoma
    View official trial listing →
  • Completed NCT NCT05602597

    HMPL-689 Drug Interaction Study With CYP3A Inhibitor/CYP2C9 Inhibitor/CYP3A Inducer/PPI

    Not yet reported Hutchmed 59 participants Est. completion 2022-08-06 1 site Stand-alone
    Other conditions: Relapsed or Refractory Lymphoma
    View official trial listing →
  • Status unknown NCT NCT05604261

    A Study of Anaprazole Sodium Enteric-coated Tablets in the Treatment of Reflux Esophagitis

    Not yet reported Xuanzhu Biopharmaceutical Co., Ltd. 156 participants Est. completion 2024-03 1 site Stand-alone
    Other conditions: Reflux Esophagitis, Gastroesophageal Reflux, Esophagitis, Esophageal Motility Disorders, Deglutition Disorders, Esophageal Diseases, Gastrointestinal Diseases
    View official trial listing →
  • Not yet recruiting NCT NCT05624229

    Efficacy of Proton Pump Inhibitors in Cirrhotic Patients With Acute Variceal Bleeding

    Not yet reported West China Hospital 672 participants Est. completion 2028-12-31
    Other conditions: Upper Gastrointestinal Hemorrhage
    View official trial listing →
  • Completed NCT NCT05630677

    A Study to Compare Bioavailability of AZD5055 Film-coated Tablet With AZD5055 Oral Suspension and to Assess the Effect of Food and an Acid Reducing Agent on Pharmacokinetics (PK) of AZD5055 in Healthy Subjects.

    Not yet reported AstraZeneca 21 participants Est. completion 2023-02-09 1 site Stand-alone
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Status unknown NCT NCT05699070

    Drug-drug Interactions Between DWC202211 and DWC202212 in Healthy Subjects

    Not yet reported Daewoong Pharmaceutical Co. LTD. 24 participants Est. completion 2023-06-01 1 site Stand-alone
    Other conditions: Drug-drug Interaction
    View official trial listing →
  • Status unknown NCT NCT05718609

    Efficacy of Therapy Based on Fecal Molecular Antimicrobial Susceptibility Tests for Helicobacter Pylori Infection

    Not yet reported Second Affiliated Hospital, Zhejiang University, School of Medicine 855 participants Est. completion 2024-06-30 1 site Stand-alone
    Other conditions: Helicobacter Pylori Infection
    View official trial listing →
  • Completed NCT NCT05857163

    Efficacy and Safety of Rifasutenizol (TNP 2198), Rabeprazole and Amoxicillin in Participants With H. Pylori Infection

    Not yet reported TenNor Therapeutics (Suzhou) Limited 700 participants Est. completion 2024-03-26 1 site Stand-alone
    Other conditions: H.Pylori Infection
    View official trial listing →
  • Status unknown NCT NCT05870397

    Optimal Recheck Time for Helicobacter Pylori Eradication: A Prospective Randomized Trial

    Not yet reported Second Affiliated Hospital, Zhejiang University, School of Medicine 900 participants Est. completion 2024-08-21 1 site
    Other conditions: Helicobacter Pylori Eradication
    View official trial listing →
  • Status unknown NCT NCT05879029

    Clinical Study of Jinsang Liyan Capsules Combined With PPI in the Treatment of LPRD

    Not yet reported Tongji Hospital 72 participants Est. completion 2024-12 1 site Stand-alone
    Other conditions: Laryngopharyngeal Reflux
    View official trial listing →
  • Status unknown NCT NCT05893849

    Pharmacokinetics of Clinical Probes and Characteristics of Endogenous Biomarker in Chinese Older Adults

    Peking University Third Hospital 624 participants Est. completion 2024-04 1 site
    Other conditions: Aging
    View official trial listing →
  • Completed NCT NCT05899829

    Evaluation of the Effect of Rifampin and Rabeprazole on the Pharmacokinetics of Camlipixant

    Not yet reported Bellus Health Inc. - a GSK company 42 participants Est. completion 2023-08-08 1 site Stand-alone
    Other conditions: Cough, Healthy
    View official trial listing →
  • Completed NCT NCT05918822

    A Study of Maribavir Pediatric Formulation in Healthy Adult Participants

    Not yet reported Takeda 32 participants Est. completion 2023-09-01 1 site Stand-alone
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT05923411

    A Study for Multiple Tablet Forms of The Study Medicine (PF-07220060) in Healthy Adults

    Not yet reported Pfizer 113 participants Est. completion 2024-07-19 1 site Stand-alone
    Other conditions: Healthy Participants
    View official trial listing →
  • Completed NCT NCT05930119

    HMPL-453 Food Effect and PPI Study in Healthy Volunteer Study

    Not yet reported Hutchmed 24 participants Est. completion 2023-08-28 1 site Stand-alone
    Other conditions: Intrahepatic Cholangiocarcinoma
    View official trial listing →
  • Status unknown NCT NCT06004401

    The Observation on the Efficacy of Dual Therapy Based on Vonoprazan in Eradicating Helicobacter Pylori

    Not yet reported Shanghai Changzheng Hospital 400 participants Est. completion 2025-12-31
    Other conditions: The Eradication Rate of Helicobacter Pylori
    View official trial listing →
  • Status unknown NCT NCT06037122

    Efficacy of Low-dose Vonoprazan for Helicobacter Pylori Eradication

    Second Affiliated Hospital, Zhejiang University, School of Medicine 558 participants Est. completion 2024-06
    Other conditions: Helicobacter Pylori Infection
    View official trial listing →
  • Completed NCT NCT06054464

    A Study to Investigate the Effects of Acid Reducing Agents on Pharmacokinetics of PC14586 in Healthy Participants

    Not yet reported PMV Pharmaceuticals, Inc 28 participants Est. completion 2024-02-06 1 site Stand-alone
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT06076681

    A Study to Evaluate Preliminary Helicobacter Pylori Eradication After Multiple Doses of TNP-2198 Capsules Combined With Rabeprazole Sodium Enteric-coated Tablets, or Rabeprazole Sodium Enteric-coated Tablets and Amoxicillin Capsules

    Not yet reported, Not yet reported TenNor Therapeutics (Suzhou) Limited 40 participants Est. completion 2022-01-06 1 site Stand-alone
    Other conditions: Helicobacter Pylori Infection
    View official trial listing →
  • Completed NCT NCT06076694

    Efficacy and Safety After Multiple Doses of TNP-2198 Capsules, Rabeprazole Sodium Enteric-coated Tablets and Amoxicillin Capsules in Helicobacter Pylori Infected-positive Participants

    Not yet reported TenNor Therapeutics (Suzhou) Limited 80 participants Est. completion 2022-09-20 1 site Stand-alone
    Other conditions: Helicobacter Pylori Infection
    View official trial listing →
  • Completed NCT NCT06105983

    A Study to Learn How a Medicine That Reduces Stomach Acid Affects the Level of Sisunatovir in the Blood of Healthy Adults.

    Not yet reported Pfizer 40 participants Est. completion 2024-07-19 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Status unknown NCT NCT06126029

    Effect of Metformin as Add-on Therapy to Ibuprofen on Disease Activity in Knee Osteoarthritis Patients.

    Not yet reported Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh 68 participants Est. completion 2024-06-30 1 site Stand-alone
    Osteoarthritis Other conditions: Metformin
    View official trial listing →
  • Status unknown NCT NCT06168214

    Standard or Short-course Vonoprazan Non-bismuth Triple Therapy or High-dose Dual Therapy Versus Rabeprazole-bismuth Quadruple Therapy for Primary Helicobacter Pylori Eradication

    Not yet reported Xijing Hospital of Digestive Diseases 1404 participants Est. completion 2024-12-25 1 site
    Other conditions: the Eradication Rates of Helicobacter Pylori
    View official trial listing →
  • Completed NCT NCT06264440

    A Study to Assess the Potential for Gastric-pH Dependent Drug-Drug Interactions of BIIB122 With a Proton Pump Inhibitor in Healthy Participants

    Not yet reported Biogen 18 participants Est. completion 2024-06-18 1 site Stand-alone
    Other conditions: Healthy Volunteer
    View official trial listing →
  • Completed NCT NCT06268834

    Is Long-Term Proton Pump Inhibitor Use a Cause of Leaky Gut Syndrome

    Not yet reported Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital 75 participants Est. completion 2023-12-31 1 site Stand-alone
    Other conditions: Proton Pump Inhibitor Adverse Reaction
    View official trial listing →
  • Completed NCT NCT06337604

    The Safety and Tolerability, Pharmacokinetics of TNP-2092 Capsules in Combination With Rabeprazole Sodium Enteric-coated Tablets

    Not yet reported TenNor Therapeutics Inc. 20 participants Est. completion 2017-11-23 1 site Stand-alone
    Other conditions: Helicobacter Pylori Infection
    View official trial listing →
  • Completed NCT NCT06399315

    Study of Single and Multiple Ascending Doses of ZE46-0134 in Healthy Volunteers

    Not yet reported Lomond Therapeutics Holdings, Inc. 112 participants Est. completion 2025-08-26 1 site Stand-alone
    Other conditions: AML
    View official trial listing →
  • Completed NCT NCT06417229

    Study to Evaluate Safety, Drug Levels, Food and Relative Bioavailability of BMS-986365 in Healthy Adult Male Participants

    Not yet reported Celgene 102 participants Est. completion 2025-02-19 1 site Stand-alone
    Other conditions: Healthy Participants
    View official trial listing →
  • Status unknown NCT NCT06481371

    Zuojin Wan Combined With Rabeprazole or Mosapride for the Treatment of Functional Dyspepsia Combined With Depression

    Not yet reported Nanjing First Hospital, Nanjing Medical University 120 participants Est. completion 2025-04-30 Stand-alone
    Other conditions: Functional Dyspepsia, Depression
    View official trial listing →
  • Completed NCT NCT06787131

    Clinical Study Aiming to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of a Single Administration of ZE50-0134 at 5 Dose Levels in Healthy Volunteers

    Not yet reported Lomond Therapeutics Holdings, Inc. 104 participants Est. completion 2025-07-04 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Active, not recruiting NCT NCT06899061

    Modular Clinical Pharmacology Study to Evaluate the Drug-drug Interaction Potential and Relative Bioavailability of Saruparib

    Not yet reported AstraZeneca 41 participants Est. completion 2028-05-19 4 sites
    Other conditions: Advanced Solid Malignancies
    View official trial listing →
  • Terminated NCT NCT06916143

    Comparing the Extent to Which Three Different Formulations of LY4100511 (DC-853) Are Made Available in the Body, Alone and in the Presence of a Drug That Reduces Stomach Acid

    Not yet reported Eli Lilly and Company 1 participants Est. completion 2025-04-08 2 sites Stand-alone
    Other conditions: Healthy Participants
    View official trial listing →
  • Not yet recruiting NCT NCT07076914

    Prophylactic Proton Pump Inhibition for Esophageal Protection in Lung Radiation Therapy

    Not yet reported London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 58 participants Est. completion 2032-10-02 1 site Stand-alone
    Other conditions: Primary Lung Cancer, Non Small Cell Lung Cancer, Small Cell Lung Cancer
    View official trial listing →
  • Completed NCT NCT07141381

    A Study to Evaluate the Effect of Food and a Proton Pump Inhibitor on the Pharmacokinetics of VRN110755

    Not yet reported Voronoi, Inc 25 participants Est. completion 2026-04-16 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT07171619

    Evaluate the Effects of Famotidine or Rabeprazole on the PK of Nirogacestat

    Not yet reported SpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, Germany 24 participants Est. completion 2025-11-10 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT07211880

    Helicobacter Pylori Infection and Gastric Disease in Bhutan: First Community-Wide, Population-Based Study

    Not yet reported Zero Helicobacter IGAN Network 1043 participants Est. completion 2023-03-21 1 site Stand-alone
    Other conditions: H.Pylori, Gastric Cancer, H Pylori Eradication
    View official trial listing →
  • Completed NCT NCT07284173

    A Study to Learn if a Medicine That Reduces Stomach Acid Affects the Blood Level of Study Medicine PF-08049820 in Healthy Chinese Adults.

    Not yet reported Pfizer 18 participants Est. completion 2025-12-18 2 sites Stand-alone
    Other conditions: Healthy Adults
    View official trial listing →
  • Completed NCT NCT07329972

    A Study to Evaluate the Effect of Food and Proton Pump Inhibitor on the Pharmacokinetics of ZN-A-1041 in Healthy Participants

    Not yet reported Genentech, Inc. 24 participants Est. completion 2025-12-14 2 sites Stand-alone
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Not yet recruiting NCT NCT07339956

    Yiwei Jiaohuang Ointment for Gastrointestinal Bleeding Associated With Oral Antithrombotic Agents

    Not yet reported China-Japan Friendship Hospital 60 participants Est. completion 2026-08-30 1 site Stand-alone
    Other conditions: Gastrointestinal Bleeding
    View official trial listing →
  • Completed NCT NCT07408271

    The Impact of Helicobacter Pylori Eradication on the Vaginal Microecology Change

    Second Affiliated Hospital, Zhejiang University, School of Medicine 83 participants Est. completion 2024-03-24 1 site
    Other conditions: Helicobacter Pylori Infection, Helicobacter Pylori Eradication Antibiotic
    View official trial listing →
  • Completed NCT NCT07563894

    Relative Bioavailability and Impact of Rabeprazole for PF-07799933, Food-Effect for PF-07799933 and PF-07799544

    Not yet reported Pfizer 16 participants Est. completion 2026-06-26 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Not yet recruiting NCT NCT07608536

    Comparison of Rabeprazole and Vonoprazan in the Prevention of Post-endoscopic Variceal Ligation Ulcer in Patients With Cirrhosis

    Not yet reported King George's Medical University 300 participants Est. completion 2026-07-31 1 site Stand-alone
    Other conditions: Endoscopic Variceal Band Ligation
    View official trial listing →
  • Active, not recruiting NCT NCT07608666

    Study to Evaluate the Effect of Rabeprazole Sodium Enteric-coated Tablets on the Pharmacokinetics of TQ05105 Tablets

    Not yet reported Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 17 participants Est. completion 2026-12 1 site
    Other conditions: Myelofibrosis
    View official trial listing →
  • Not yet recruiting NCT NCT07611162

    Comparative Effectiveness of Alginate, Magaldrate, Sucralfate, Proton Pump Inhibitors, and Diet in Laryngopharyngeal Reflux Disease

    Not yet reported University of Mons 800 participants Est. completion 2030-05-01 1 site
    Other conditions: Laryngopharyngeal Reflux Disease
    View official trial listing →
  • Active, not recruiting NCT NCT07643272

    A Study on the Effect of Food and Proton Pump Inhibitor on the Pharmacokinetics of HMPL-760 Capsules

    Not yet reported Hutchmed 24 participants Est. completion 2026-12 1 site Stand-alone
    Other conditions: Healthy Participants
    View official trial listing →
  • Not yet recruiting NCT NCT07788053

    Efficacy And Safety of Bismuth-Tetracycline-Rabeprazole Triple For First-Line Eradication of Helicobacter Pylori Infection

    Not yet reported Chih-An Shih, MD 300 participants Est. completion 2029-09-01 1 site
    Other conditions: Helicobatcer Pylori, First-Line Eradication
    View official trial listing →
Efficacy history

Not yet reported.

Safety

Not yet reported.

Sources

Also known as: Rabeprazole Sodium, Rabeprazole

Related On The Pen coverage

No related coverage yet.

This drug may be investigational and not yet approved for any use. Whether someone can join a clinical trial is determined only by that trial's own study team — On The Pen does not determine eligibility. Information here can change; always confirm current details on the official ClinicalTrials.gov listing or with the sponsor.